319 related articles for article (PubMed ID: 23071587)
1. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract][Full Text] [Related]
2. A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.
Edmond V; Merdzhanova G; Gout S; Brambilla E; Gazzeri S; Eymin B
Cell Cycle; 2013 Apr; 12(8):1267-78. PubMed ID: 23518498
[TBL] [Abstract][Full Text] [Related]
3. Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin.
Edmond V; Moysan E; Khochbin S; Matthias P; Brambilla C; Brambilla E; Gazzeri S; Eymin B
EMBO J; 2011 Feb; 30(3):510-23. PubMed ID: 21157427
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
5. SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines.
Edmond V; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Cell Cycle; 2011 Jun; 10(12):1968-77. PubMed ID: 21555914
[TBL] [Abstract][Full Text] [Related]
6. Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
Boukakis G; Patrinou-Georgoula M; Lekarakou M; Valavanis C; Guialis A
BMC Cancer; 2010 Aug; 10():434. PubMed ID: 20716340
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P
RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
[TBL] [Abstract][Full Text] [Related]
9. More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells.
Zhang SY; Hui LP; Li CY; Gao J; Cui ZS; Qiu XS
BMC Cancer; 2016 Feb; 16():171. PubMed ID: 26926340
[TBL] [Abstract][Full Text] [Related]
10. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of SRPK2 promotes cell cycle arrest though E2F1 in non-small cell lung cancer.
Li X; Yang S; Zhang M; Xie S; Xie Z
Eur J Histochem; 2019 Dec; 63(4):. PubMed ID: 31833327
[TBL] [Abstract][Full Text] [Related]
12. S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.
Wang R; Li Y; Hu E; Kong F; Wang J; Liu J; Shao Q; Hao Y; He D; Xiao X
Oncotarget; 2017 Apr; 8(15):24804-24814. PubMed ID: 28177901
[TBL] [Abstract][Full Text] [Related]
13. Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.
Stojsic J; Stankovic T; Stojkovic S; Milinkovic V; Dinic J; Milosevic Z; Milovanovic Z; Tanic N; Bankovic J
Exp Mol Pathol; 2015 Feb; 98(1):27-32. PubMed ID: 25449334
[TBL] [Abstract][Full Text] [Related]
14. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
Shultz JC; Goehe RW; Murudkar CS; Wijesinghe DS; Mayton EK; Massiello A; Hawkins AJ; Mukerjee P; Pinkerman RL; Park MA; Chalfant CE
Mol Cancer Res; 2011 Jul; 9(7):889-900. PubMed ID: 21622622
[TBL] [Abstract][Full Text] [Related]
15. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.
Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T
BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676
[TBL] [Abstract][Full Text] [Related]
16. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung.
Kim SH; Kim JM; Shin MH; Kim CW; Huang SM; Kang DW; Suh KS; Yi ES; Kim KH
Histol Histopathol; 2012 May; 27(5):581-91. PubMed ID: 22419022
[TBL] [Abstract][Full Text] [Related]
17. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
[TBL] [Abstract][Full Text] [Related]
18. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
19. Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-rich Splicing Factors 1 and 2 via an Arginine/Serine-like Region and Counteracts Their Alternative Splicing Activity.
Kim CH; Kim YD; Choi EK; Kim HR; Na BR; Im SH; Jun CD
J Biol Chem; 2016 Mar; 291(12):6169-81. PubMed ID: 26797131
[TBL] [Abstract][Full Text] [Related]
20. The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
Moreno P; Lara-Chica M; Soler-Torronteras R; Caro T; Medina M; Álvarez A; Salvatierra Á; Muñoz E; Calzado MA
PLoS One; 2015; 10(11):e0143376. PubMed ID: 26580787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]